School of Medicine


Showing 41-60 of 100 Results

  • Hilary Jericho

    Hilary Jericho

    Clinical Associate Professor, Pediatrics - Gastroenterology

    Current Research and Scholarly InterestsI am a clinical associate professor of pediatric gastroenterology and the Inaugural Medical Director of the Celiac Disease Program at the Lucile Packard Children’s Hospital at Stanford whose clinical practice and research have an emphasis on the diagnosis and management of celiac disease. I was appointed the Director of Pediatric Clinical Research at the University of Chicago Celiac Disease Center in 2014. I am deeply involved in both local community and national professional societies serving as the Director of the Chicagoland Children’s Health Alliance (CCHA) endoscopy committee and am a member of the CCHA celiac committee, the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) celiac special interest group, CeliacKids (a pediatric multi-center celiac research focused collaborative), the Standards-Based Active Guideline Environment (a committee responsible for the establishment of guidelines for accommodating children with celiac disease within school settings across the United States), and the NASPGHAN Endoscopy committee. My clinical work and research focus on pediatric celiac disease (CeD) and have resulted in numerous publications, peer-reviewed articles, and book chapters. This research has also helped to establish myself as an expert in the field of pediatric celiac disease leading to invitations to speak and be a moderator at both local and national meetings, including the internationally attended University of Chicago Celiac Disease Center educational preceptorship programs, the NASPGHAN annual meeting and Beyond Celiac. I have additionally been called up to provide celiac specific journal reviews as well as expert opinions to leading publications, including US News and World Report, Reader’s Digest and Reuter’s. The current application builds logically on my prior work in the field of pediatric celiac disease for which I have successfully administered the projects (staffing, research coordination, budgeting, data analysis and manuscript creation). In summary, I have the expertise, leadership, training, and motivation necessary to successfully carry out the proposed research projects.

  • John Kerner

    John Kerner

    Professor of Pediatrics (Gastroenterology), Emeritus

    Current Research and Scholarly InterestsI am interested in pediatric nutritional support and have experience evaluating new enteral and parenteral products especially for the neonate (I studied a "new" I.V. fat product for Abbott; I participated in a multicenter trial of a formula with fish oil in it for neonates with Mead Johnson and a multicenter trial of a new human milk fortifier for Wyeth).

  • Kian Keyashian

    Kian Keyashian

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.

  • Nasim Sabery Khavari

    Nasim Sabery Khavari

    Clinical Associate Professor, Pediatrics - Gastroenterology

    Current Research and Scholarly InterestsPediatric Gastroenterology, Celiac Disease, Nutrition in Celiac Disease

  • Chaitan Khosla

    Chaitan Khosla

    Wells H. Rauser and Harold M. Petiprin Professor and Professor of Chemistry and, by courtesy, of Biochemistry

    Current Research and Scholarly InterestsResearch in this laboratory focuses on problems where deep insights into enzymology and metabolism can be harnessed to improve human health.

    For the past two decades, we have studied and engineered enzymatic assembly lines called polyketide synthases that catalyze the biosynthesis of structurally complex and medicinally fascinating antibiotics in bacteria. An example of such an assembly line is found in the erythromycin biosynthetic pathway. Our current focus is on understanding the structure and mechanism of this polyketide synthase. At the same time, we are developing methods to decode the vast and growing number of orphan polyketide assembly lines in the sequence databases.

    For more than a decade, we have also investigated the pathogenesis of celiac disease, an autoimmune disorder of the small intestine, with the goal of discovering therapies and related management tools for this widespread but overlooked disease. Ongoing efforts focus on understanding the pivotal role of transglutaminase 2 in triggering the inflammatory response to dietary gluten in the celiac intestine.

  • Calvin Kuo

    Calvin Kuo

    Maureen Lyles D'Ambrogio Professor

    Current Research and Scholarly InterestsWe study cancer biology, intestinal stem cells (ISC), and angiogenesis. We use primary organoid cultures of diverse tissues and tumor biopsies for immunotherapy modeling, oncogene functional screening and stem cell biology. Angiogenesis projects include blood-brain barrier regulation, stroke therapeutics and anti-angiogenic cancer therapy. ISC projects apply organoid culture and ko mice to injury-inducible vs homeostatic stem cells and symmetric division mechanisms.

  • Bomi Lee

    Bomi Lee

    Instructor, Pediatrics - Gastroenterology

    Current Research and Scholarly InterestsImmune mechanisms in pancreatic diseases, pancreatitis and pancreatic cancer

  • Grace Lee

    Grace Lee

    Professor of Pediatrics (Infectious Diseases)

    BioDr. Grace Lee is Chief Quality Officer and the Christopher G. Dawes Endowed Director of Quality at Stanford Medicine Children’s Health and Lucile Packard Children’s Hospital Stanford, and Associate Dean for Maternal and Child Health (Quality and Safety) and Professor of Pediatrics at Stanford University School of Medicine. She oversees the Center for Pediatric and Maternal Value that seeks to improve quality, safety, patient experience and health equity across the organization. Dr. Lee previously served as a member of the Institute of Medicine Committee (IOM) to Review Priorities in the National Vaccine Plan, the IOM Committee on the Ethical and Scientific Issues in Studying the Safety of Approved Drugs, the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response, and AHRQ's Healthcare Safety and Quality Improvement Research Study Section. She also served as a Board Member for the Society for Healthcare Epidemiology of America (SHEA), Pediatric Infectious Diseases Society (PIDS), and the National Academy of Medicine (NAM) Board on Population Health and Public Health Practice. She was previously the Chair of the U.S. Advisory Committee on Immunization Practices (ACIP) that recommends vaccines for the U.S. population, and she is an elected member of the National Academy of Medicine.

  • Mary Leonard

    Mary Leonard

    Arline and Pete Harman Professor and Professor of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.